Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.59 -0.39 (-3.96%)
As of: Sep 30, 2026 · 10:25 AM EDT

Xeris Biopharma Holdings (XERS) Receivables - Net (2020 - 2026)

Updated

Xeris Biopharma Holdings (XERS) posted Receivables - Net of $58.11 million for Q2 2026, up 9.5% from $53.05 million a year earlier and up 3.2% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Receivables - Net (2020 - 2026) Analysis & Trends

At the end of FY2025, Xeris Biopharma Holdings' Receivables - Net came in at $51.05 million, up 26.3% from FY2024.

  • Annual Receivables - Net has increased for five consecutive years, with a five-year compound annual growth rate of 49.3% (FY2020 to FY2025).
  • In prior years, Xeris Biopharma Holdings' Receivables - Net was $40.42 million in FY2024 (+3.1%), $39.2 million in FY2023 (+27.1%), $30.83 million in FY2022 (+76.6%) and $17.46 million in FY2021 (+153.9%).
  • The Q2 2026 figure stands as the highest quarterly Receivables - Net in data going back to Q4 2020.
  • On a year-over-year basis, Receivables - Net has increased in each of the last seven quarters, with growth averaging 16.2% over the last eight quarters.
  • The strongest year-over-year quarter for Receivables - Net in the past five years was Q4 2021, with growth of 153.9%; the weakest was Q3 2024, with a decline of 10.5%.
  • According to Business Quant data, Receivables - Net for the three prior quarters was $56.3 million (Q1 2026), $51.05 million (Q4 2025) and $53.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Xeris Biopharma Holdings 1.71 Bn 1.27 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 58.11 Mn
Mar 31, 2026 56.30 Mn
Dec 31, 2025 51.05 Mn
Sep 30, 2025 53.75 Mn
Jun 30, 2025 53.05 Mn
Mar 31, 2025 46.33 Mn
Dec 31, 2024 40.42 Mn
Sep 30, 2024 41.14 Mn
Jun 30, 2024 42.44 Mn
Mar 31, 2024 37.41 Mn
Dec 31, 2023 39.20 Mn
Sep 30, 2023 45.97 Mn
Jun 30, 2023 30.23 Mn
Mar 31, 2023 30.86 Mn
Dec 31, 2022 30.83 Mn
Sep 30, 2022 27.52 Mn
Jun 30, 2022 25.76 Mn
Mar 31, 2022 23.38 Mn
Dec 31, 2021 17.46 Mn
Sep 30, 2021 13.56 Mn
API Access

Xeris Biopharma Holdings Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=XERS&period=max&api_key=YOUR_API_KEY